This week we will finish up our very first season of the LUNG FORCE Podcast Series by bringing you a conversation around an exciting topic and something you may not have heard of before - targeted therapies! Listen in as we hear from AstraZeneca Oncology representative, LUNG FORCE Committee Member and new Leadership Board Member, Paul Gorman on testing and treatment options and advancements! During this episode, we'll learn about the importance of molecular testing and the ins-and-outs of targeted therapies (treatments in the form of a pill that work on specific cancer mutations) including who is eligible for a targeted therapy treatment. It's so important to keep educating, funding and performing research around testing and treatment - and this episode is just one example why!
Learn more about AstraZeneca Oncology and their areas of expertise by visiting www.astrazeneca.com.
As always, make sure to follow the LUNG FORCE Walk Buffalo Facebook Group for updates and information, and reach out to BuffaloWalk@lung.org for questions or to get in touch!
